Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1320-1327

  Sharif, Adnan ^a   Alachkar, Nada ^b   Bagnasco, Serena ^b   Geetha, Duvuru ^b   Gupta, Gaurav ^b   Womer, Karl ^b   Arend, Lois ^b   Racusen, Lorraine ^b   Montgomery, Robert ^b   Kraus, Edward ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; CREATININE;

ADULT; AGED; ARTICLE; BK VIRUS ALLOGRAFT NEPHROPATHY; BLOOD GROUP ABO INCOMPATIBILITY; CAPILLARITIS; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULITIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA TYPING; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHENOTYPE; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BALTIMORE; BIOLOGICAL MARKERS; BIOPSY; BK VIRUS; BLOOD GROUP INCOMPATIBILITY; CHI-SQUARE DISTRIBUTION; COMPLEMENT C4B; CREATININE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDE FRAGMENTS; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 84864804330     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00770112     Document Type: Article

References (35)

1. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J: Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347: 488-496, 2002
2. Ramos E, Drachenberg CB, Wali R, Hirsch HH: The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 87: 621-630, 2009
3. Dall A, Hariharan S: BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 3[Suppl 2]: S68-S75, 2008
4. Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch MJ: Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant 24: 1024-1033, 2009
5. Garonzik Wang JM, Montgomery RA, Kucirka LM, Berger JC, Warren DS, Segev DL: Incompatible live-donor kidney transplantation in the United States: Results of a national survey. Clin J Am Soc Nephrol 6: 2041-2046, 2011
6. Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, CooperM, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M: ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 87: 1246-1255, 2009
7. Takahashi K, Saito K, Takahara S, Okuyama A, Tanabe K, TomaH, Uchida K, Hasegawa A, Yoshimura N, Kamiryo Y; Japanese ABOIncompatible Kidney Transplantation Committee: Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4: 1089-1096, 2004
8. Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G: ABOincompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation 85: 1745-1754, 2008
9. Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King KE, Shirey RS, Simpkins CE, Montgomery RA: Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4: 1315-1322, 2004
10. Haidinger M, Schmaldienst S, Körmöczi G, Regele H, Soleiman A, Schwartz D, Derfler K, Steininger R, Mühlbacher F, Böhmig GA: Vienna experience of ABO-incompatible living-donor kidney transplantation. Wien KlinWochenschr 121: 247-255, 2009
11. Oettl T, Halter J, Bachmann A, Guerke L, Infanti L, Oertli D, Mihatsch M, Gratwohl A, Steiger J, Dickenmann M: ABO blood group-incompatible living donor kidney transplantation: A prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant 24: 298-303, 2009
12. Habicht A, Bröker V, Blume C, Lorenzen J, Schiffer M, Richter N, Klempnauer J, Haller H, Lehner F, Schwarz A: Increase of infectious complications in ABO-incompatible kidney transplant recipients-a single centre experience. Nephrol Dial Transplant 26: 4124-4131, 2011
13. Flint SM, Walker RG, Hogan C, Haeusler MN, Robertson A, Francis DM, Millar R, Finlay M, Landgren A, Cohney SJ: Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression. Am J Transplant 11: 1016-1024, 2011
14. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, MaleyWR, Ratner LE: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70: 887-895, 2000
15. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, BaldwinW, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8: 753-760, 2008
16. Geetha D, Parkhie S, Nadkarni GN, He C, Shafi T: Polyomavirusassociated nephropathy: A comparison of 2 different strategies for immunosuppression reduction. Medicine (Baltimore) 90: 296-302, 2011
17. Matsumoto A, Namba Y, Yazawa K, Ichimaru N, Miyagawa Y, Takahara S, Okuyama A, Kim M, Kojima Y, Kokado Y, Kyo M: [A case report of BK virus nephropathy after an ABO-incompatible living kidney transplantation]. Nippon Hinyokika Gakkai Zasshi 94: 685-688, 2003
18. Itabashi Y, Sakai K, Kawamura T, Hyodo Y, MuramatsuM, Arai K, Aikawa A, Mizuiri S, Ohara T, Hasegawa C, Ishikawa Y, Hasegawa A: BK virus nephropathy in a patient with ABOincompatible renal transplantation. Clin Transplant 18[Suppl 11]: 39-43, 2004
19. Fuchinoue S, Ishii Y, Sawada T, Murakami T, Iwadoh K, Sannomiya A, Koyama I, Kubota K, Tojimbara T, Nakajima I, Teraoka S: The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation 91: 853-857, 2011
20. Crew RJ, Ratner LE: ABO-incompatible kidney transplantation: Current practice and the decade ahead. Curr Opin Organ Transplant 15: 526-530, 2010
21. Babel N, Volk HD, Reinke P: BK polyomavirus infection and nephropathy: The virus-immune system interplay. Nat Rev Nephrol 7: 399-406, 2011
22. Lynch RJ, Platt JL: Accommodation in renal transplantation: Unanswered questions. Curr Opin Organ Transplant 15: 481-485, 2010
23. Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA: C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J AmSoc Nephrol 20: 197-204, 2009
24. Zachary AA, Montgomery RA, Ratner LE, Samaniego-Picota M, Haas M, Kopchaliiska D, Leffell MS: Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 76: 1519-1525, 2003
25. Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES: Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 7: 576-585, 2007
26. Randhawa PS, Schonder K, Shapiro R, Farasati N, Huang Y: Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation 89: 1462-1465, 2010
27. Jordan SC, Toyoda M, Vo AA: Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev Clin Immunol 7: 341-348, 2011
28. Mengel M, Marwedel M, Radermacher J, Eden G, Schwarz A, Haller H, Kreipe H: Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 18: 1190-1196, 2003
29. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC: BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 10: 407-415, 2010
30. Buehrig CK, Lager DJ, StegallMD, Kreps MA, KremersWK, Gloor JM, Schwab TR, Velosa JA, Fidler ME, Larson TS, Griffin MD: Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 64: 665-673, 2003
31. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin III WM, Bracamonte ER, Broecker V, Cosio F, Demetris A, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, RegeleH, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A: Banff '09 meeting report: Antibody mediated graft deterioration and implementation of BanffWorking Groups. Am J Transplant 10: 464-471, 2009
32. Drachenberg CB, Papadimitriou JC, HirschHH, Wali R, Crowder C, Nogueira J, Cangro CB, Mendley S, Mian A, Ramos E: Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 4: 2082-2092, 2004
33. Matsutani K, Shapiro R, Basu A, TanH, WijkstromM, Randhawa P: The Banff 2009 working proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant 12: 907-918, 2012
34. Sar A, Worawichawong S, Benediktsson H, Zhang J, Yilmaz S, Trpkov K: Interobserver agreement for polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum Pathol 42: 2018-2024, 2011
35. Singh HK, Andreoni KA, Madden V, True K, Detwiler R, Weck K, Nickeleit V: Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 20: 416-427, 2009